US Stock MarketDetailed Quotes

SBHMY SINO BIOPHARMACEUT

Watchlist

7.200
0.0000.00%

15min DelayTrading Apr 24 16:00 ET

6.76BMarket Cap20.69P/E (TTM)

SINO BIOPHARMACEUT Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

Total revenue

-8.97%26.2B

7.14%28.78B

13.59%26.86B

10.66%7.11B

16.41%7.24B

-2.42%23.65B

12.38%5.52B

-19.36%5.48B

1.69%6.43B

0.22%6.22B

Operating revenue

-8.97%26.2B

7.14%28.78B

13.59%26.86B

10.66%7.11B

16.41%7.24B

-2.42%23.65B

12.38%5.52B

-19.36%5.48B

1.69%6.43B

0.22%6.22B

Cost of revenue

-13.90%4.99B

8.69%5.8B

2.89%5.33B

-12.31%1.34B

11.75%1.42B

5.20%5.18B

-4.10%1.11B

-2.77%1.28B

23.08%1.53B

4.45%1.27B

Gross profit

-7.72%21.21B

6.76%22.98B

16.60%21.53B

17.81%5.77B

17.60%5.83B

-4.37%18.46B

17.44%4.41B

-23.36%4.2B

-3.53%4.9B

-0.80%4.96B

Operating expense

-13.64%10.7B

-1.22%12.39B

9.80%12.54B

26.23%2.2B

16.97%4.57B

-1.06%11.42B

23.11%2.79B

-10.30%2.98B

-41.82%1.74B

32.00%3.9B

Selling and administrative expenses

-11.92%11.07B

-1.10%12.56B

9.25%12.7B

20.32%3.29B

19.44%3.5B

-1.43%11.63B

19.58%2.97B

-10.42%2.99B

-9.04%2.73B

-1.17%2.93B

-Selling and marketing expense

-11.26%9.19B

-1.51%10.36B

17.23%10.52B

23.12%2.61B

22.58%3.05B

-3.72%8.97B

22.44%2.11B

-15.45%2.25B

-14.43%2.12B

1.47%2.49B

-General and administrative expense

-15.03%1.87B

0.89%2.2B

-17.72%2.19B

10.65%678.3M

1.69%448.06M

7.21%2.66B

13.11%862.62M

9.38%739.67M

16.29%613.04M

-13.85%440.6M

Research and development costs

----

4.18%1.01B

----

--973.82M

Other operating expenses

----

525.52%69.01M

----

--11.03M

Operating profit

-0.80%10.51B

17.90%10.6B

27.63%8.99B

13.17%3.58B

19.94%1.26B

-9.28%7.04B

8.80%1.62B

-43.59%1.21B

51.31%3.16B

-48.43%1.05B

Net non-operating interest income expense

-29.86%-308.56M

-62.13%-237.62M

-13.29%-146.56M

-259.72%-30.3M

-34.16%-17.62M

-566.03%-129.37M

-1,472.08%-71.16M

-361.84%-36.66M

-1,132.11%-8.42M

-269.27%-13.13M

Non-operating interest income

-7.33%186.68M

24.30%201.44M

-16.47%162.06M

-40.02%45.27M

-30.08%54.04M

-24.72%194M

-113.01%-13.25M

-10.78%54.48M

45.31%75.47M

80.33%77.3M

Non-operating interest expense

12.80%495.24M

42.27%439.06M

-4.56%308.62M

-9.93%75.56M

-20.76%71.66M

40.63%323.37M

-40.09%57.91M

93.64%91.14M

64.10%83.89M

157.59%90.43M

Other net income (expense)

Special income (charges)

-156.31%-47.04M

612.71%83.54M

-455.76%-16.29M

488.15%794K

387.21%1.07M

407.20%4.58M

127.34%4.12M

-99.32%108K

--135K

--219K

-Less：Restructuring and merger&acquisition

81.55%-16.54M

-846.23%-89.67M

--12.02M

----

-Less:Other special charges

937.99%63.59M

43.20%6.13M

193.41%4.28M

-488.15%-794K

-387.21%-1.07M

-407.20%-4.58M

-127.34%-4.12M

---108K

---135K

---219K

Other non- operating income (expenses)

-3.24%-4.55B

-2.28%-4.41B

-61.29%-4.31B

-4.80%-1.76B

156.28%49.87M

-6.18%-2.67B

-82.57%-872.49M

67.92%-133.99M

-130.17%-1.68B

102.19%19.46M

Income before tax

-6.38%5.41B

-68.89%5.78B

270.49%18.57B

517.66%8.14B

119.74%2.84B

-11.91%5.01B

5.57%1.27B

-38.98%1.13B

-5.49%1.32B

4.32%1.29B

Income tax

2.74%797.27M

-60.37%775.99M

191.19%1.96B

169.81%889.97M

106.47%446.94M

-25.52%672.38M

-249.41%-105.32M

-39.53%231.37M

38.92%329.86M

2.01%216.47M

Net income

1.89%5.1B

-69.89%5B

282.77%16.61B

633.84%7.25B

122.41%2.39B

-9.34%4.34B

21.40%1.38B

-38.84%898.44M

-14.61%987.57M

4.79%1.08B

Net income continuous Operations

-7.80%4.61B

-69.89%5B

282.77%16.61B

633.84%7.25B

122.41%2.39B

-9.34%4.34B

21.40%1.38B

-38.84%898.44M

-14.61%987.57M

4.79%1.08B

Net income discontinuous operations

--484.76M

----

Minority interest income

12.46%2.77B

22.56%2.46B

27.83%2.01B

9.25%680.35M

139.53%480.92M

-22.54%1.57B

-27.28%457.51M

-56.13%288.55M

9.48%622.74M

17.67%200.77M

Net income attributable to the parent company

-8.32%2.33B

-82.59%2.54B

427.17%14.61B

1,700.00%6.57B

118.49%1.91B

0.35%2.77B

81.93%920.59M

-24.81%609.89M

-37.92%364.83M

2.23%875.79M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-8.32%2.33B

-82.59%2.54B

427.17%14.61B

1,700.00%6.57B

118.49%1.91B

0.35%2.77B

81.93%920.59M

-24.81%609.89M

-37.92%364.83M

2.23%875.79M

Basic earnings per share

-7.83%2.518

-82.45%2.732

428.02%15.566

1,702.06%6.992

118.67%2.038

0.41%2.948

80.59%0.986

-25.41%0.642

-37.69%0.388

2.79%0.932

Diluted earnings per share

3.62%2.518

-83.42%2.43

397.01%14.652

1,657.73%6.82

151.49%1.856

0.41%2.948

80.59%0.986

-25.41%0.642

-37.69%0.388

-18.60%0.738

Dividend per share

-14.58%1.4873

74.41%1.7411

-15.21%0.9983

36.46%0.6659

23.52%1.1773

40.66%0.337

45.40%0.3523

3.56%0.488

Currency Unit

CNY

Accounting Standards

NonUS-GAAP

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020
Total revenue	-8.97%26.2B	7.14%28.78B	13.59%26.86B	10.66%7.11B	16.41%7.24B	-2.42%23.65B	12.38%5.52B	-19.36%5.48B	1.69%6.43B	0.22%6.22B
Operating revenue	-8.97%26.2B	7.14%28.78B	13.59%26.86B	10.66%7.11B	16.41%7.24B	-2.42%23.65B	12.38%5.52B	-19.36%5.48B	1.69%6.43B	0.22%6.22B
Cost of revenue	-13.90%4.99B	8.69%5.8B	2.89%5.33B	-12.31%1.34B	11.75%1.42B	5.20%5.18B	-4.10%1.11B	-2.77%1.28B	23.08%1.53B	4.45%1.27B
Gross profit	-7.72%21.21B	6.76%22.98B	16.60%21.53B	17.81%5.77B	17.60%5.83B	-4.37%18.46B	17.44%4.41B	-23.36%4.2B	-3.53%4.9B	-0.80%4.96B
Operating expense	-13.64%10.7B	-1.22%12.39B	9.80%12.54B	26.23%2.2B	16.97%4.57B	-1.06%11.42B	23.11%2.79B	-10.30%2.98B	-41.82%1.74B	32.00%3.9B
Selling and administrative expenses	-11.92%11.07B	-1.10%12.56B	9.25%12.7B	20.32%3.29B	19.44%3.5B	-1.43%11.63B	19.58%2.97B	-10.42%2.99B	-9.04%2.73B	-1.17%2.93B
-Selling and marketing expense	-11.26%9.19B	-1.51%10.36B	17.23%10.52B	23.12%2.61B	22.58%3.05B	-3.72%8.97B	22.44%2.11B	-15.45%2.25B	-14.43%2.12B	1.47%2.49B
-General and administrative expense	-15.03%1.87B	0.89%2.2B	-17.72%2.19B	10.65%678.3M	1.69%448.06M	7.21%2.66B	13.11%862.62M	9.38%739.67M	16.29%613.04M	-13.85%440.6M
Research and development costs	----	----	----	----	4.18%1.01B	----	----	----	----	--973.82M
Other operating expenses	----	----	----	----	525.52%69.01M	----	----	----	----	--11.03M
Operating profit	-0.80%10.51B	17.90%10.6B	27.63%8.99B	13.17%3.58B	19.94%1.26B	-9.28%7.04B	8.80%1.62B	-43.59%1.21B	51.31%3.16B	-48.43%1.05B
Net non-operating interest income expense	-29.86%-308.56M	-62.13%-237.62M	-13.29%-146.56M	-259.72%-30.3M	-34.16%-17.62M	-566.03%-129.37M	-1,472.08%-71.16M	-361.84%-36.66M	-1,132.11%-8.42M	-269.27%-13.13M
Non-operating interest income	-7.33%186.68M	24.30%201.44M	-16.47%162.06M	-40.02%45.27M	-30.08%54.04M	-24.72%194M	-113.01%-13.25M	-10.78%54.48M	45.31%75.47M	80.33%77.3M
Non-operating interest expense	12.80%495.24M	42.27%439.06M	-4.56%308.62M	-9.93%75.56M	-20.76%71.66M	40.63%323.37M	-40.09%57.91M	93.64%91.14M	64.10%83.89M	157.59%90.43M
Other net income (expense)
Special income (charges)	-156.31%-47.04M	612.71%83.54M	-455.76%-16.29M	488.15%794K	387.21%1.07M	407.20%4.58M	127.34%4.12M	-99.32%108K	--135K	--219K
-Less：Restructuring and merger&acquisition	81.55%-16.54M	-846.23%-89.67M	--12.02M	----	----	----	----	----	----	----
-Less:Other special charges	937.99%63.59M	43.20%6.13M	193.41%4.28M	-488.15%-794K	-387.21%-1.07M	-407.20%-4.58M	-127.34%-4.12M	---108K	---135K	---219K
Other non- operating income (expenses)	-3.24%-4.55B	-2.28%-4.41B	-61.29%-4.31B	-4.80%-1.76B	156.28%49.87M	-6.18%-2.67B	-82.57%-872.49M	67.92%-133.99M	-130.17%-1.68B	102.19%19.46M
Income before tax	-6.38%5.41B	-68.89%5.78B	270.49%18.57B	517.66%8.14B	119.74%2.84B	-11.91%5.01B	5.57%1.27B	-38.98%1.13B	-5.49%1.32B	4.32%1.29B
Income tax	2.74%797.27M	-60.37%775.99M	191.19%1.96B	169.81%889.97M	106.47%446.94M	-25.52%672.38M	-249.41%-105.32M	-39.53%231.37M	38.92%329.86M	2.01%216.47M
Net income	1.89%5.1B	-69.89%5B	282.77%16.61B	633.84%7.25B	122.41%2.39B	-9.34%4.34B	21.40%1.38B	-38.84%898.44M	-14.61%987.57M	4.79%1.08B
Net income continuous Operations	-7.80%4.61B	-69.89%5B	282.77%16.61B	633.84%7.25B	122.41%2.39B	-9.34%4.34B	21.40%1.38B	-38.84%898.44M	-14.61%987.57M	4.79%1.08B
Net income discontinuous operations	--484.76M	----	----	----	----	----	----	----	----	----
Minority interest income	12.46%2.77B	22.56%2.46B	27.83%2.01B	9.25%680.35M	139.53%480.92M	-22.54%1.57B	-27.28%457.51M	-56.13%288.55M	9.48%622.74M	17.67%200.77M
Net income attributable to the parent company	-8.32%2.33B	-82.59%2.54B	427.17%14.61B	1,700.00%6.57B	118.49%1.91B	0.35%2.77B	81.93%920.59M	-24.81%609.89M	-37.92%364.83M	2.23%875.79M
Preferred stock dividends
Other preferred stock dividends	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-8.32%2.33B	-82.59%2.54B	427.17%14.61B	1,700.00%6.57B	118.49%1.91B	0.35%2.77B	81.93%920.59M	-24.81%609.89M	-37.92%364.83M	2.23%875.79M
Basic earnings per share	-7.83%2.518	-82.45%2.732	428.02%15.566	1,702.06%6.992	118.67%2.038	0.41%2.948	80.59%0.986	-25.41%0.642	-37.69%0.388	2.79%0.932
Diluted earnings per share	3.62%2.518	-83.42%2.43	397.01%14.652	1,657.73%6.82	151.49%1.856	0.41%2.948	80.59%0.986	-25.41%0.642	-37.69%0.388	-18.60%0.738
Dividend per share	-14.58%1.4873	74.41%1.7411	-15.21%0.9983	36.46%0.6659	0	23.52%1.1773	40.66%0.337	45.40%0.3523	3.56%0.488	0
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall